Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy. Observational, Descriptive, Open-label, Multi-centric, Non-randomized Study
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Vigabatrin (Primary)
- Indications Infantile spasms; Partial epilepsies
- Focus Therapeutic Use
- Acronyms SoluWest
- Sponsors Targeon
- 25 Aug 2015 Endpoints and treatment details modified as per protocol amendment reported by ClinicalTrials.gov.
- 25 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.
- 25 Aug 2014 New trial record